CORRECTION article

Front. Neurol., 05 January 2023

Sec. Headache and Neurogenic Pain

Volume 13 - 2022 | https://doi.org/10.3389/fneur.2022.1123725

Corrigendum: No change in interictal C-reactive protein levels in individuals with episodic and chronic migraine: A case-control study and literature review

  • 1. Heart-Immune-Brain Network Research Center, Department of Life Science, Ewha Womans University, Seoul, Republic of Korea

  • 2. Laboratory of Immunology, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea

  • 3. Therapeutic Antibody Research Center, Genuv Inc., Seoul, Republic of Korea

  • 4. Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea

In the published article, there was an error in the Funding statement. A National Research Foundation of Korea (NRF) grant was incorrectly omitted. The correct Funding statement appears below.

Statements

Funding

This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant No.: HV22C0106) and a National Research Foundation of Korea (NRF) grant from the Korean government (MSIT) (2022R1A2C1091767).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

biomarker, C-reactive protein, inflammation, migraine, headache

Citation

Park CG, Lee SH and Chu MK (2023) Corrigendum: No change in interictal C-reactive protein levels in individuals with episodic and chronic migraine: A case-control study and literature review. Front. Neurol. 13:1123725. doi: 10.3389/fneur.2022.1123725

Received

14 December 2022

Accepted

15 December 2022

Published

05 January 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Min Kyung Chu ✉

This article was submitted to Headache and Neurogenic Pain, a section of the journal Frontiers in Neurology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics